COMBINATION THERAPY WITH AN ANTI-CD25 ANTIBODY-DRUG CONJUGATE

The present disclosure relates to combination therapies for the treatment of pathological conditions, such as cancer. In particular, the present disclosure relates to combination therapies comprising treatment with an Antibody Drug Conjugate (ADC) and a secondary agent. La présente invention concern...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FEINGOLD, Jay Marshall, WUERTHNER, Jens, SKELTON, Lisa, HARTLEY, John, VAN BERKEL, Patricius Hendrikus Cornelis, ZAMMARCHI, Francesca
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure relates to combination therapies for the treatment of pathological conditions, such as cancer. In particular, the present disclosure relates to combination therapies comprising treatment with an Antibody Drug Conjugate (ADC) and a secondary agent. La présente invention concerne des polythérapies pour le traitement d'états pathologiques, tels que le cancer. En particulier, la présente invention concerne des polythérapies comprenant un traitement avec un Conjugué Anticorps-Médicament (CAM) et un agent secondaire.